THE DUBERSTEIN GROUP INC.

Lobbying for GILEAD SCIENCES, INC. · Biotechnology company that researches, develops and commercializes drugs.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $90,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Issues related to drug pricing Issues related to 340B program

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.